Kadcyla 100mg Injection

About this Medicine

Kadcyla 100mg Injection is a medicine used to treat a certain type of cancer called HER2-positive metastatic breast cancer. It specifically targets the HER2 protein in cancer cells. This slows tumor growth and reduces tumor size with minimum effects on healthy cells. Kadcyla 100mg Injection is administered through an intravenous (IV) infusion under the supervision of a doctor or a nurse, typically in a clinic or hospital setting. It is given once every three weeks, and each infusion session may take around 30–90 minutes, depending on individual treatment needs. Attend all scheduled infusion sessions to maintain consistent drug levels for maximum benefits.Common side effects of Kadcyla 100mg Injection include fatigue, nausea, vomiting, headache, constipation, mild liver enzyme changes, and muscle or joint pain. If you experience nausea, try eating small, frequent meals and avoid heavy or greasy foods. Fatigue can be managed by resting when needed and pacing activities. Let your doctor know if any of these side effects persist or worsen. They may be able to help ways to reduce or prevent the side effects.Before receiving this medicine, inform your doctor if you have a history of liver or heart issues, as this medication can affect these organs. This treatment is not recommended for pregnant women, as it may harm the unborn baby; women of childbearing age should use effective contraception during treatment and for several months after. Additionally, avoid breastfeeding during and after treatment, as the drug may pass into breast milk.There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

How it Works

Kadcyla 100mg Injection seeks out and latches onto cancer cells with a protein called HER2. HER2-positive cancer cells have a lot of this protein, which helps them grow quickly. Once Kadcyla 100mg Injection attaches to a HER2-positive cell, it goes inside the cell and helps kill the cancer cell from the inside without affecting as many healthy cells around it.

Key Facts

Chemical Class :: Peptides|Habit Forming :: No|Therapeutic Class :: ANTI NEOPLASTICS|Action Class :: Monoclonal antibodies

Safety Overview